# OS Therapies (OSTX) — News

OSTX · AMEX · Stock

Canonical page: https://www.lighthorse.io/tickers/ostx/news

## Recent headlines

- [Biontech SE - Trial will continue to evaluate second dual primary endpoint of overall survival](https://www.ainvest.com/news/biontech-se-trial-continue-evaluate-dual-primary-endpoint-survival-2610) — AInvest Wire, Oct 13, 2026
  BioNTech SE (NASDAQ: BNTX) has announced that its ongoing Phase 2 clinical trial will continue to evaluate the second dual primary endpoint of overall survival (OS) for the investigational therapy. The trial is assessing the safety and efficacy of the treatment in a specific patient population,…
- [OS Therapies - Christopher P. Acevedo ceases as CFO, to continue as consultant - SEC filing](https://www.ainvest.com/news/os-therapies-christopher-acevedo-ceases-cfo-continue-consultant-sec-filing-2610) — AInvest Wire, Oct 5, 2026
  OS Therapies, Inc. (OSTX) has announced that Christopher P. Acevedo has stepped down as Chief Financial Officer, effective immediately. Acevedo will continue to serve the company in a consulting capacity. The transition follows a recent SEC filing, which outlines the change in leadership without…
- [OS Therapies - Appoints Francis (Frank) Knuettel II as CFO effective Sept 29, 2026 - SEC filing](https://www.ainvest.com/news/os-therapies-appoints-francis-frank-knuettel-ii-cfo-effective-sept-29-2026-sec-filing-2610) — AInvest Wire, Oct 5, 2026
  OS Therapies, Inc. has announced the appointment of Francis (Frank) Knuettel II as Chief Financial Officer, effective September 29, 2026, as disclosed in a recent SEC filing. Knuettel brings extensive financial leadership experience to the role, with a background in biotechnology and life sciences…
- [Os Therapies enters open market sale agreement with Jefferies - SEC filing](https://www.ainvest.com/news/os-therapies-enters-open-market-sale-agreement-jefferies-sec-filing-2608) — AInvest Wire, Aug 21, 2026
- [My Size enters $10 mln equity purchase agreement with Square Gate Capital over 36 months - SEC filing](https://www.ainvest.com/news/size-enters-10-mln-equity-purchase-agreement-square-gate-capital-36-months-sec-filing-2608) — AInvest Wire, Aug 5, 2026
  OS Therapies Inc. (NYSE American: OSTX) has entered into an equity purchase agreement with Square Gate Capital Master Fund, LLC-Series 3, under which the company may sell up to $15 million in shares of its common stock over a 24-month period, as disclosed in a recent SEC filing. The agreement,…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).